A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Surgical Treatment for Benign Prostate Hyperplasia in Hong Kong
Sponsor study identifier
observational
2,000
1 country
3
Study Start
April 1, 2022
Actual (reported)Primary Completion
April 30, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
July 31, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This is a prospective data registry to assess the treatment outcomes and complications of different treatment approaches in our hospital clusters.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 31, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 15, 2022
Actual (reported)March 23, 2022
Actual (reported)April 1, 2022
Actual (reported)April 30, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
July 31, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
International Prostate Symptom Score (IPSS) questionnaire total Score
Change in total scores in International Prostate Symptom Score (ranges from 0 to 35) questionnaires
Baseline, 3 months after surgical treatment for BPH
Voiding function in uroflowmetry
Change in urodynamic function assessed by Uroflowmetry
Baseline, 3 months after after surgical treatment for BPH
Complication after surgical treatment
Post operation 30 days after surgical treatment for BPH
Patients diagnosed with BPH and planned for surgery (including all type of endoscopic procedures) in the hospitals will be identified and then enrolled to the study
Alice Ho Miu Ling Nethersole Hospital
Hong Kong, Hong Kong
North District Hospital
Hong Kong, Hong Kong
Kahokehr A, Gilling PJ. Landmarks in BPH--from aetiology to medical and surgical management. Nat Rev Urol. 2014 Feb;11(2):118-22. doi: 10.1038/nrurol.2013.318. Epub 2014 Jan 21.
Magistro G, Chapple CR, Elhilali M, Gilling P, McVary KT, Roehrborn CG, Stief CG, Woo HH, Gratzke C. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms. Eur Urol. 2017 Dec;72(6):986-997. doi: 10.1016/j.eururo.2017.07.005. Epub 2017 Jul 19.
Chi Fai NG, MD
Chinese University of Hong Kong
First Submitted
March 15, 2022
First Posted
March 23, 2022
Study Start
April 1, 2022
Actual (reported)Primary Completion
April 30, 2032
EstimatedSTEAM-MAP 1 Study - Steam Therapy With MRI and AI-assisted Planning
Contact the study team to confirm eligibility.
Prince of Wales Hospital
Shatin, Hong Kong
Faber K, de Abreu AL, Ramos P, Aljuri N, Mantri S, Gill I, Ukimura O, Desai M. Image-guided robot-assisted prostate ablation using water jet-hydrodissection: initial study of a novel technology for benign prostatic hyperplasia. J Endourol. 2015 Jan;29(1):63-9. doi: 10.1089/end.2014.0304.
Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezum((R)) system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015 Jan 30;7:13-8. doi: 10.2147/RRU.S74040. eCollection 2015.
Siu BWH, Leung DKW, Wong RSK, Wong CHM, Liu AQ, Yee CH, Teoh JYC, Chiu PKF, Ng CF, Lo KL. Thulium fiber laser enucleation of the prostate with SOLTIVE SuperPulsed laser systems: a prospective evaluation of early outcomes in an Asian cohort. Front Urol. 2026 Mar 30;6:1753089. doi: 10.3389/fruro.2026.1753089. eCollection 2026.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
July 31, 2032
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 22, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: